OncoImmune reported positive results from a late-stage study of a coronavirus therapeutic candidate. "Merck to Buy OncoImmune Amid Covid-19 Vaccine Development," at 6:45 a.m. ET incorrectly said that OncoImmune reported positive results from a late-stage study of a coronavirus vaccine candidate.

 

(END) Dow Jones Newswires

November 23, 2020 08:22 ET (13:22 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more Merck Charts.